Members |
acceptabilityId |
5-guanidino-2-oxopentanoate decarboxylase |
Preferred (foundation metadata concept) |
5-guanidino-2-oxopentanoate decarboxylase (substance) |
Preferred (foundation metadata concept) |
5-hydroperoxy-6,8,11,14-eicosatetraenoic acid |
Preferred (foundation metadata concept) |
5-hydroperoxy-6,8,11,14-eicosatetraenoic acid (substance) |
Preferred (foundation metadata concept) |
5-hydroxy tryptamine |
Acceptable (foundation metadata concept) |
5-hydroxy tryptophan |
Acceptable (foundation metadata concept) |
5-hydroxy-1,4-naphthoquinone |
Acceptable (foundation metadata concept) |
5-hydroxy-N-methylpyroglutamate synthase |
Acceptable (foundation metadata concept) |
5-hydroxy-alphanaphthaquinone |
Acceptable (foundation metadata concept) |
5-hydroxyfuranocoumarin O^5^-methyltransferase |
Preferred (foundation metadata concept) |
5-hydroxyfuranocoumarin O^5^-methyltransferase (substance) |
Preferred (foundation metadata concept) |
5-hydroxyhexanoate |
Preferred (foundation metadata concept) |
5-hydroxyhexanoate (substance) |
Preferred (foundation metadata concept) |
5-hydroxyhistamine |
Preferred (foundation metadata concept) |
5-hydroxyhistamine (substance) |
Preferred (foundation metadata concept) |
5-hydroxyindole acetic acid |
Preferred (foundation metadata concept) |
5-hydroxyindole acetic acid (substance) |
Preferred (foundation metadata concept) |
5-hydroxyindoleacetate |
Acceptable (foundation metadata concept) |
5-hydroxyindoleacetic acid |
Acceptable (foundation metadata concept) |
5-hydroxymethoxyphenamine |
Acceptable (foundation metadata concept) |
5-hydroxypentanoate CoA-transferase |
Preferred (foundation metadata concept) |
5-hydroxypentanoate coenzyme A-transferase |
Acceptable (foundation metadata concept) |
5-hydroxypentanoate coenzyme A-transferase (substance) |
Preferred (foundation metadata concept) |
5-hydroxytryptamine |
Acceptable (foundation metadata concept) |
5-hydroxytryptamine secreting neuroendocrine tumor |
Acceptable (foundation metadata concept) |
5-hydroxytryptamine secreting neuroendocrine tumor (disorder) |
Preferred (foundation metadata concept) |
5-hydroxytryptamine-3-receptor antagonist |
Acceptable (foundation metadata concept) |
5-hydroxytryptamine-3-receptor antagonist (disposition) |
Preferred (foundation metadata concept) |
5-hydroxytryptamine-3-receptor antagonist allergy |
Acceptable (foundation metadata concept) |
5-hydroxyvalerate CoA-transferase |
Acceptable (foundation metadata concept) |
5-iodo-2'-deoxycytidine |
Acceptable (foundation metadata concept) |
5-item World Health Organization Well-being Index questionnaire |
Preferred (foundation metadata concept) |
5-item World Health Organization Well-being Index questionnaire (assessment scale) |
Preferred (foundation metadata concept) |
5-item World Health Organization Well-being Index value |
Preferred (foundation metadata concept) |
5-item World Health Organization Well-being Index value (observable entity) |
Preferred (foundation metadata concept) |
5-keto-2-deoxygluconokinase |
Acceptable (foundation metadata concept) |
5-keto-D-fructose reductase |
Acceptable (foundation metadata concept) |
5-keto-D-fructose reductase (NADP^+^) |
Acceptable (foundation metadata concept) |
5-keto-D-gluconate 2-reductase |
Acceptable (foundation metadata concept) |
5-keto-D-gluconate 5-reductase |
Acceptable (foundation metadata concept) |
5-keto4-deoxy-glucarate dehydratase |
Acceptable (foundation metadata concept) |
5-lipoxygenase inhibitor |
Preferred (foundation metadata concept) |
5-lipoxygenase inhibitor |
Preferred (foundation metadata concept) |
5-lipoxygenase inhibitor (disposition) |
Preferred (foundation metadata concept) |
5-lipoxygenase inhibitor-containing product |
Preferred (foundation metadata concept) |
5-methoxypsoralen |
Preferred (foundation metadata concept) |
5-methoxypsoralen (substance) |
Preferred (foundation metadata concept) |
5-methoxypsoralen only product |
Preferred (foundation metadata concept) |
5-methoxypsoralen-containing product |
Preferred (foundation metadata concept) |
5-methyl-3-heptanone |
Preferred (foundation metadata concept) |
5-methyl-3-heptanone (substance) |
Preferred (foundation metadata concept) |
5-methyl-8-quinolinol |
Acceptable (foundation metadata concept) |
5-methyldeoxycytidine-5'-phosphate kinase |
Preferred (foundation metadata concept) |
5-methyldeoxycytidine-5'-phosphate kinase (substance) |
Preferred (foundation metadata concept) |
5-methyltetrahydrofolate |
Preferred (foundation metadata concept) |
5-methyltetrahydrofolate (substance) |
Preferred (foundation metadata concept) |
5-methyltetrahydrofolate homocysteine methyltransferase measurement |
Preferred (foundation metadata concept) |
5-methyltetrahydrofolate homocysteine methyltransferase measurement (procedure) |
Preferred (foundation metadata concept) |
5-methyltetrahydrofolate-homocysteine methyltransferase |
Preferred (foundation metadata concept) |
5-methyltetrahydrofolate-homocysteine methyltransferase (substance) |
Preferred (foundation metadata concept) |
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase |
Preferred (foundation metadata concept) |
5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase (substance) |
Preferred (foundation metadata concept) |
5-methylthioribose kinase |
Preferred (foundation metadata concept) |
5-methylthioribose kinase (substance) |
Preferred (foundation metadata concept) |
5-methylthioribose-1-phosphate isomerase |
Preferred (foundation metadata concept) |
5-methylthioribose-1-phosphate isomerase (substance) |
Preferred (foundation metadata concept) |
5-nitro-2-furfuryl methyl ether |
Acceptable (foundation metadata concept) |
5-oxo-L-proline |
Acceptable (foundation metadata concept) |
5-oxopent-3-ene-1,2,5-tricarboxylate decarboxylase |
Preferred (foundation metadata concept) |
5-oxopent-3-ene-1,2,5-tricarboxylate decarboxylase (substance) |
Preferred (foundation metadata concept) |
5-oxoprolinase |
Preferred (foundation metadata concept) |
5-oxoprolinase (ATP-hydrolysing) |
Preferred (foundation metadata concept) |
5-oxoprolinase (adenosine triphosphate-hydrolysing) |
Acceptable (foundation metadata concept) |
5-oxoprolinase (adenosine triphosphate-hydrolysing) (substance) |
Preferred (foundation metadata concept) |
5-oxoprolinase (substance) |
Preferred (foundation metadata concept) |
5-oxoproline |
Acceptable (foundation metadata concept) |
5-oxoprolyl-peptidase |
Preferred (foundation metadata concept) |
5-oxoprolyl-peptidase (substance) |
Preferred (foundation metadata concept) |
5-phosphoribosylamine synthetase |
Acceptable (foundation metadata concept) |
5-phosphoribosylimidazoleacetate synthetase |
Acceptable (foundation metadata concept) |
5-pyridoxate dioxygenase |
Preferred (foundation metadata concept) |
5-pyridoxate dioxygenase (substance) |
Preferred (foundation metadata concept) |
5-pyridoxate oxidase |
Acceptable (foundation metadata concept) |
5-trimethoxyamphetamine |
Preferred (foundation metadata concept) |
5-trimethoxyamphetamine (substance) |
Preferred (foundation metadata concept) |
5-ureidohydantoin |
Acceptable (foundation metadata concept) |
5-valerolactone |
Acceptable (foundation metadata concept) |
5.02 |
Preferred (foundation metadata concept) |
5.02 (qualifier value) |
Preferred (foundation metadata concept) |
5.2 |
Preferred (foundation metadata concept) |
5.2 (qualifier value) |
Preferred (foundation metadata concept) |
5.26 |
Preferred (foundation metadata concept) |
5.26 (qualifier value) |
Preferred (foundation metadata concept) |
5.3 |
Preferred (foundation metadata concept) |
5.3 (qualifier value) |
Preferred (foundation metadata concept) |
5.30 o'clock position |
Preferred (foundation metadata concept) |
5.30 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
5.33 |
Preferred (foundation metadata concept) |
5.33 (qualifier value) |
Preferred (foundation metadata concept) |
5.4 |
Preferred (foundation metadata concept) |
5.4 (qualifier value) |
Preferred (foundation metadata concept) |